Healthcare cost for non-hospital services and pharmaceuticals among breast cancer survivors: an event study

Key Points

• Healthcare costs significantly increase among breast cancer survivors, particularly for non-hospital services.
• Event study analysis shows a substantial rise in expenditures related to pharmaceuticals and non-hospital services after treatment.
• The study assesses the economic burden through various cost metrics over a set period among breast cancer survivors.
• Findings underscore the need for policy measures to manage rising healthcare costs for this population.